Who We Serve

Meeting unique, complex forecasting needs
for companies like yours

We work with large and mid-sized pharmaceutical and biotechnology companies as well as emerging specialty firms.

Our team can also support financial and investment firms, including private equity and venture capital, as they build portfolios in the pharmaceutical and biotechnology sectors.

Our experienced principals and consultants can support decision-makers across all levels of your organization, including Sales and Marketing, Decision Sciences, Finance, Corporate Development, and C-Suite executives.

Select Clients

Gilead
Aptevo
Mallinckrodt
Melinta
Takeda
Chiesi
Helsinn
AcastiPharma
Ipsen
astellas
Pharmacosmos
Zogenix
collegium
taro
Horizon
Whoweserve
CollegiumPharmaceuticals
dexcom
genmap
medexus

Across multiple projects, Viscadia has listened to our needs and prioritized delivery of key insights that help us gain alignment with the broader team. Their specialization in oncology forecasting has made each forecast creation a breeze, and expanding and updating our models has been seamless. In rapidly changing therapeutic areas, Viscadia's forecasts have withstood the test of time!

Sarah Yue

Sarah Yue

Director, Oncology HCP Marketing, Pfizer

I have worked with Viscadia across many companies and clients. I keep returning to them because they stay on point, grasp and incorporate changes quickly, and their team can provide a different view on market dynamics, rendering the overall output much more robust. The realism in Viscadia’s approach made it extremely easy to communicate to internal stakeholders and ultimately get traction on my projects. I cannot wait to work with them again.

Irina Baramova

Irina Baramova

Chief Business Officer, CleanSite Medical

Viscaida brought additional dimensions to the existing forecast, which aided buy-in from our stakeholders. I needed someone to work alongside me, and they were the ideal partner.

Rob Hernandez

Rob Hernandez

Senior Director, Forecasting & Financial Planning, Daiichi Sankyo, Inc.

Viscadia has been a long-term strategic partner to Milestone on the forecasting front. In addition to their responsiveness and innovative modeling techniques, they have deep therapeutic expertise which enables us to expand our own thinking and ultimately make more informed decisions.

Lorenz Muller

Lorenz Muller

Chief Commercial Officer, Milestones Pharmaceuticals, Inc.

Our forecast was accurate... that was a critical piece of allowing us to complete a successful and valuable acquisition.

Josh Franklin

Josh Franklin

President, Pharmacosmos Therapeutics Inc.

captcha
protected by reCAPTCHA